Info
Dr. Mary Pinder of Moffitt Cancer Center reviews the CUSTOM trial, in which the study of molecular markers was expanded to patients with small cell lung cancer and thymic carcinomas.
9 years ago
#2013, #asco, #cancer, #cancergrace, #carcinoma, #cell, #center, #custom, #grace, #gracecast, #institute, #lung, #markers, #mary, #moffitt, #molecular, #pinder, #small, #swedish, #trial
Discover more
Search
